Firebird Diagnostics envisions a patient diagnostics experience where:

• Single samples are examined by single tests that have single-test costs.
• One test detects any DNA or RNA that might be causing a patient disease.
• The result is returned rapidly, often on the site where the sample is taken.

Firebird's team advances the science of DNA, creating new kinds of DNA and enzymes to manipulate them.

The team then applies its advances to pathogen surveillance, human diagnostics, and pandemic management.

Firebird has several diagnostic products with approval on the market, and several more in our pipeline.

Firebird's products are characterized by (a) the ability to detect in one step all possible pathogens in a sample, (b) ultra-cleanliness, with few false positives and few false negatives, and (c) rapid results.

Firebird also transfers its chemistry to partners to empower their instruments and devices.

Partner with us to learn how our technology platforms can help you meet you needs in diagnostics, surveillance, and biotechnology.